NIH-funded research U01 cooperative agreement

Diabetes that can start after acute pancreatitis

Official title: Type 1 Diabetes in Acute Pancreatitis Consortium – Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D

Funded at Benaroya Research Inst at Virginia Mason · NIH-11234743 · Data updated 2026-11-12

This project follows people who had acute pancreatitis to find out how and why diabetes can begin afterward.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionBenaroya Research Inst at Virginia Mason
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 16, 2020
Project endJuly 31, 2030
Funding year2025
Award (this year)$517,100
NIH project number2U01DK127404-06
Project IDNIH-11234743 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults recently hospitalized for acute pancreatitis who do not already have established diabetes and are willing to attend follow-up visits and provide blood samples.

Less likely to help

People without a history of acute pancreatitis or those with long-standing diabetes unrelated to pancreatic injury are unlikely to benefit directly from this project.

What this research studies

If you recently had acute pancreatitis, researchers will enroll you in a long-term follow-up where they collect health information and blood samples over time. The team will use detailed immune testing and diabetes-related hormone measurements to see which kinds of diabetes develop after pancreatitis. Ten clinical centers in a consortium will enroll participants to get a large, consistent picture of risk factors and timing. The goal is to link immune changes and clinical features to the appearance of diabetes so future detection and care can improve.

Why it matters

Potential benefit: If successful, this work could help identify people at high risk for diabetes after pancreatitis so they can get earlier monitoring and tailored care.

How similar studies have gone: Previous retrospective studies have reported higher diabetes rates after pancreatitis, but large prospective, immune-focused follow-up like this is relatively new.

Where this research is happening

  • Benaroya Research Inst at Virginia Mason
    Seattle, United States
    Active

Researchers

  • Principal investigator: Speake, Cate — Benaroya Research Inst at Virginia Mason
  • Study coordinator: Speake, Cate

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.